KYLE KELLER

Allopathic & Osteopathic Physicians|Family Medicine DUBLIN, OH NPI 1083176622

General Payments — all program years on this page

$181.25

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 9
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $133.46 across 6 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $133.466

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $37.092
Amgen Inc. $29.531
Xeris Pharmaceuticals, Inc. $23.561
Lilly USA, LLC $22.121
GlaxoSmithKline, LLC. $21.161

By program year

Program yearAmountRecords
2023 $47.793
2024 $133.466

Records — PY2024 (6)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104048556 ABBVIE INC. $20.50 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104048558 ABBVIE INC. $16.59 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111616657 Amgen Inc. $29.53 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116519824 GlaxoSmithKline, LLC. $21.16 01/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135138774 Lilly USA, LLC $22.12 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144602103 Xeris Pharmaceuticals, Inc. $23.56 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.